In last trading session, Novavax, Inc. (NASDAQ:NVAX) saw 9.16 million shares changing hands with its beta currently measuring 1.59. Company’s recent per share price level of $4.83 trading at -$0.11 or -2.23% at ring of the bell on the day assigns it a market valuation of $675.96M. That closing price of NVAX’s stock is at a discount of -135.2% from its 52-week high price of $11.36 and is indicating a premium of 26.92% from its 52-week low price of $3.53. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.77 million shares which gives us an average trading volume of 9.09 million if we extend that period to 3-months.
Novavax, Inc. (NASDAQ:NVAX) trade information
Upright in the red during last session for losing -2.23%, in the last five days NVAX remained trading in the red while hitting it’s week-highest on Friday, 03/15/24 when the stock touched $4.83 price level, adding 10.56% to its value on the day. Novavax, Inc.’s shares saw a change of 0.62% in year-to-date performance and have moved -8.00% in past 5-day. Novavax, Inc. (NASDAQ:NVAX) showed a performance of 16.95% in past 30-days. Number of shares sold short was 52.74 million shares which calculate 4.83 days to cover the short interests.
Novavax, Inc. (NVAX) estimates and forecasts
Statistics highlight that Novavax, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -37.11% of value to its shares in past 6 months, showing an annual growth rate of 88.72% while that of industry is 12.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 73.00% in the current quarter and calculating -289.70% decrease in the next quarter. This year revenue growth is estimated to fall -13.30% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $100.6 million for the same. And 3 analysts are in estimates of company making revenue of $102.2 million in the next quarter that will end on Jun 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.55% during past 5 years.
NVAX Dividends
Novavax, Inc. is more likely to be releasing its next quarterly report between May 07 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
